Whether you're managing Type 1 or Type 2 diabetes, Canadian Insulin offers a wide selection of brand-name insulin products like Lantus, Humalog, and Novolog, all sourced from licensed Canadian ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

While tweaking your diet and eliminating unhealthy foods is vital, you don’t have to compromise on flavor or quality. Here ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Anyone hoping to start 2025 in a healthier vein may have looked to low-sugar alternatives. That may not always be wise.

Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic ...

The tennis pro is teaming up with the medical device giant to launch a global campaign aimed at inspiring people living with ...

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.